These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
672 related articles for article (PubMed ID: 20113320)
61. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma? Vrieze O; Haustermans K; De Wever W; Lerut T; Van Cutsem E; Ectors N; Hiele M; Flamen P Radiother Oncol; 2004 Dec; 73(3):269-75. PubMed ID: 15588870 [TBL] [Abstract][Full Text] [Related]
62. [Radiotherapy volume delineation based on ( Encaoua J; Abgral R; Leleu C; El Kabbaj O; Caradec P; Bourhis D; Pradier O; Schick U Cancer Radiother; 2017 Jun; 21(4):267-275. PubMed ID: 28499658 [TBL] [Abstract][Full Text] [Related]
63. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318 [TBL] [Abstract][Full Text] [Related]
64. Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning. Hong TS; Killoran JH; Mamede M; Mamon HJ Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1612-8. PubMed ID: 19028285 [TBL] [Abstract][Full Text] [Related]
65. Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary? Fried D; Lawrence M; Khandani AH; Rosenman J; Cullip T; Chera BS Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):748-54. PubMed ID: 22414285 [TBL] [Abstract][Full Text] [Related]
66. Influence of F-fluorodeoxyglucose-positron emission tomography on computed tomography-based radiation treatment planning for oesophageal cancer. Everitt C; Leong T Australas Radiol; 2006 Jun; 50(3):271-4. PubMed ID: 16732830 [TBL] [Abstract][Full Text] [Related]
67. Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box? Devic S; Tomic N; Faria S; Menard S; Lisbona R; Lehnert S Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1555-62. PubMed ID: 20646840 [TBL] [Abstract][Full Text] [Related]
68. Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma. Vees H; Casanova N; Zilli T; Imperiano H; Ratib O; Popowski Y; Wang H; Zaidi H; Miralbell R Radiat Oncol; 2012 Oct; 7():176. PubMed ID: 23088346 [TBL] [Abstract][Full Text] [Related]
69. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy. Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157 [TBL] [Abstract][Full Text] [Related]
70. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus. Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143 [TBL] [Abstract][Full Text] [Related]
71. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Nestle U; Kremp S; Grosu AL Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802 [TBL] [Abstract][Full Text] [Related]
72. [The impact of integrating images of positron emission tomography with computed tomography simulation on radiation therapy planning]. Touboul E; Deniaud-Alexandre E; Moureau-Zabotto L; Lerouge D Cancer Radiother; 2004 Nov; 8 Suppl 1():S29-35. PubMed ID: 15679244 [TBL] [Abstract][Full Text] [Related]
73. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate? Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814 [TBL] [Abstract][Full Text] [Related]
74. The application of positron emission tomography/computed tomography in radiation treatment planning: effect on gross target volume definition and treatment management. Iğdem S; Alço G; Ercan T; Unalan B; Kara B; Geceer G; Akman C; Zengin FO; Atilla S; Okkan S Clin Oncol (R Coll Radiol); 2010 Apr; 22(3):173-8. PubMed ID: 20116979 [TBL] [Abstract][Full Text] [Related]
75. A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies. Terezakis SA; Schöder H; Kowalski A; McCann P; Lim R; Turlakov A; Gonen M; Barker C; Goenka A; Lovie S; Yahalom J Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):376-83. PubMed ID: 24726287 [TBL] [Abstract][Full Text] [Related]
76. DeepTarget: Gross tumor and clinical target volume segmentation in esophageal cancer radiotherapy. Jin D; Guo D; Ho TY; Harrison AP; Xiao J; Tseng CK; Lu L Med Image Anal; 2021 Feb; 68():101909. PubMed ID: 33341494 [TBL] [Abstract][Full Text] [Related]
77. 18F-fluorodeoxyglucose positron emisson tomography/computed tomography guided conformal brachytherapy for cervical cancer. Nam H; Huh SJ; Ju SG; Park W; Lee JE; Choi JY; Kim BT; Kim CK; Park BK Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e29-34. PubMed ID: 22503526 [TBL] [Abstract][Full Text] [Related]
78. Respiratory-gated (4D) contrast-enhanced FDG PET-CT for radiotherapy planning of lower oesophageal carcinoma: feasibility and impact on planning target volume. Scarsbrook A; Ward G; Murray P; Goody R; Marshall K; McDermott G; Prestwich R; Radhakrishna G BMC Cancer; 2017 Oct; 17(1):671. PubMed ID: 28978306 [TBL] [Abstract][Full Text] [Related]
79. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas. Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512 [TBL] [Abstract][Full Text] [Related]
80. Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer. Paskeviciute B; Bölling T; Brinkmann M; Rudykina G; Ernst I; Stegger L; Schober O; Willich N; Weckesser M; Könemann S Strahlenther Onkol; 2009 Apr; 185(4):260-5. PubMed ID: 19370430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]